; (B) ulcerative colitis; (C) thyroid disease; (D) testicular cancer; (E) kidney cancer; and (F) pregnancy-induced hypertension. (2) With respect to exposure to perfluoroalkyl and polyfluoroalkyl substances not specified in paragraph (1), any other disease, illness, or condition that the Secretary, in consultation with the Administrator of the Agency for Toxic Substances and Disease Registry of the Department of Health and Human Services, determines pursuant to the study conducted under section 316 of the National Defense Authorization Act for Fiscal Year 2018 ( Public Law 115–91 ; 131 Stat. 1350) that a positive association exists between exposure to perfluoroalkyl and polyfluoroalkyl substances and such disease or illness. (c) Active military, naval, air, or space service For purposes of this section, any service by a member of the reserve components for a period specified by the Secretary at a military installation described in subsection (a)(2) shall be treated as active military, naval, air, or space service, notwithstanding section 101(24) of this title. . (b) Clerical amendment The table of sections at the beginning of such chapter is amended by inserting after the item relating to section 1116B the following new item: 1116C. Presumption of service connection for certain veterans exposed to perfluorooctanoic acid or other perfluoroalkyl and polyfluoroalkyl substances. .